In our study, we proved that methylation status of TMPRSS4 and SHOX2 can be accurately quantified by ddPCR in both plasma and BAL from NSCLC patients and healthy individuals. This evidence concerns the gene TMPRSS4 and non-small cell lung carcinoma.